Alan Huang Tango Therapeutics, Inc. (TNGX) insider trading activity
Alan Huang is Chief Scientific Officer of Tango Therapeutics, Inc.. Currently has a direct ownership of 167,584 shares of TNGX, which is worth approximately $522,862. The most recent transaction as insider was on Mar 01, 2023, when has been sold 31,697 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
168K
0%
3M change
0%
12M change
Total Value Held
$522,862
AH
Alan Huang
Chief Scientific Officer
Cambridge, MA